About this trial

This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.

Eligibility criteria

Qualifiers

Adults ≥18 years

Patient followed as part of their MAI in one of the departments participating in the study at UHM

Confirmed diagnosis according to international criteria :ACR/EULAR 2010

Adults ≥18 years

Disqualifiers

Patients who have refused or are unable to give informed consent

Inability to follow the subject during the study period

Participation in another interventional study that includes an exclusion period that is still ongoing

Pregnant women

Trial design

Treatments tested in this trial

  • Blood test and principal collection
  • Optional collection
  • Patient questionnaires
  • Examination

Treatment groups

500 Participants
are divided into 4 treatment groups

Locations

1
CHU de Montpellier - CIMA Montpellier France

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor